Golden Developing Solutions Inc
Golden Developing Solutions, Inc. operates as online health and wellness holding company. It specializes in providing specialty medicine with rapid delivery services and medical support in the United States. The company was formerly known as Clean Hydrogen Producers, Ltd and changed its name to Golden Developing Solutions, Inc. in April 2017. Golden Developing Solutions, Inc. was founded in 1998 … Read more
Golden Developing Solutions Inc (DVLP) - Net Assets
Latest net assets as of September 2023: $-1.27 Million USD
Based on the latest financial reports, Golden Developing Solutions Inc (DVLP) has net assets worth $-1.27 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.92 Million) and total liabilities ($9.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.27 Million |
| % of Total Assets | -16.09% |
| Annual Growth Rate | 78.79% |
| 5-Year Change | 4338.19% |
| 10-Year Change | N/A |
| Growth Volatility | 4695.56 |
Golden Developing Solutions Inc - Net Assets Trend (2015–2022)
This chart illustrates how Golden Developing Solutions Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Golden Developing Solutions Inc (2015–2022)
The table below shows the annual net assets of Golden Developing Solutions Inc from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $2.04 Million | +306.66% |
| 2021-12-31 | $-987.42K | -415.83% |
| 2020-12-31 | $312.64K | -93.69% |
| 2018-12-31 | $4.96 Million | +10678.08% |
| 2016-12-31 | $45.98K | +31.63% |
| 2015-12-31 | $34.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Golden Developing Solutions Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 49375.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $171.85K | 8.42% |
| Other Components | $15.63 Million | 766.05% |
| Total Equity | $2.04 Million | 100.00% |
Golden Developing Solutions Inc Competitors by Market Cap
The table below lists competitors of Golden Developing Solutions Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Fund Management Co. Ltd.- China Fund State Power New Energy Close Fund
SHG:508028
|
$14.14K |
|
Devolver Digital Inc
LSE:DEVO
|
$14.15K |
|
HAPV3F
SA:HAPV3F
|
$14.15K |
|
BIOSTIME INTL
BE:8BI
|
$14.15K |
|
LTHP
LSE:LTHP
|
$14.13K |
|
PunaMusta Media Oyj
HE:PUMU
|
$14.13K |
|
Meezan Bank Ltd
KAR:MEBL
|
$14.12K |
|
CONSOLE LABS SA ZY-10
F:9ZK
|
$14.09K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Golden Developing Solutions Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -987,421 to 2,040,590, a change of 3,028,011.
- Net loss of 1,410,505 reduced equity.
- New share issuances of 3,151,032 increased equity.
- Other factors increased equity by 1,287,484.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.41 Million | -69.12% |
| Share Issuances | $3.15 Million | +154.42% |
| Other Changes | $1.29 Million | +63.09% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Golden Developing Solutions Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.04x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.03 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Golden Developing Solutions Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -69.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 4.27x
- Recent ROE (-69.12%) is above the historical average (-388.64%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 51.11% | 1.38% | 36.84x | 1.01x | $14.36K |
| 2016 | -223.30% | -7.76% | 28.35x | 1.02x | $-107.27K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-30.23K |
| 2018 | -32.17% | -600.67% | 0.03x | 1.81x | $-2.09 Million |
| 2020 | -2446.99% | 0.00% | 0.00x | 15.33x | $-9.01 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-531.26K |
| 2022 | -69.12% | 0.00% | 0.00x | 4.27x | $-1.61 Million |
Industry Comparison
This section compares Golden Developing Solutions Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Golden Developing Solutions Inc (DVLP) | $-1.27 Million | 51.11% | N/A | $14.13K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |